Bottom line
How much do GDOC and PHSYX overlap?
54% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 55.1% of GDOC's assets and 49.4% of PHSYX's. They share a meaningful core but differ in the rest of the portfolio.
PHSYX holds far more positions (115 vs 42), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings GDOC and PHSYX have in common
| Holding | % of GDOC | % of PHSYX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 13.28% | 13.15% | 13.15% |
| Johnson & Johnson JNJ | 8.07% | 8.46% | 8.07% |
| Merck & Company Inc MRK | 5.94% | 4.88% | 4.88% |
| Astrazeneca Plc AZN | 4.84% | 4.67% | 4.67% |
| Thermo Fisher Scientific Inc TMO | 4.52% | 4.50% | 4.50% |
| Intuitive Surgical Inc ISRG | 3.90% | 4.04% | 3.90% |
| Boston Scientific Corp BSX | 3.78% | 1.80% | 1.80% |
| Hoya Corp 7741 | 3.53% | 1.52% | 1.52% |
| Edwards Lifesciences Corp EW | 2.98% | 2.80% | 2.80% |
| Dexcom Inc DXCM | 2.79% | 1.64% | 1.64% |
| Vertex Pharmaceuticals Inc VRTX | 1.48% | 1.97% | 1.48% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GDOC
- Guardant Health Inc — 5.34%
- Argenx Se — 4.07%
- Lonza Group Ag — 2.80%
- Agilent Technologies Inc — 2.77%
- Roivant Sciences Ltd — 2.39%
- Cencora Inc — 2.34%
- Apogee Therapeutics Inc — 1.97%
- Royalty Pharma Plc — 1.77%
- Penumbra Inc — 1.61%
- Mettler-toledo International Inc — 1.59%
- Goldman Sachs Trust — 1.43%
- Cytokinetics Inc — 1.40%
- Ionis Pharmaceuticals Inc — 1.37%
- Xenon Pharmaceuticals Inc — 1.35%
Only in PHSYX
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Sanofi SA — 3.23%
- Roche Holding AG — 2.79%
- CVS Health Corp. — 2.74%
- Gilead Sciences, Inc. — 2.63%
- McKesson Corp. — 2.14%
- Cardinal Health, Inc. — 2.12%
- Novo Nordisk A/S — 1.90%
- Bristol-Myers Squibb Co. — 1.75%
- Putnam Short Term Investment Fund — 1.35%
- HCA Healthcare, Inc. — 1.18%
- Amgen, Inc. — 1.11%
Asset mix
| Asset type | GDOC | PHSYX |
|---|---|---|
| Stocks | 98.5% | 98.2% |
| Cash & short-term funds | 1.4% | 0.6% |
| Other | — | 1.4% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | GDOC | PHSYX |
|---|---|---|
| US | 76.3% | 76.2% |
| CH | 3.9% | 7.9% |
| GB | 6.6% | 6.4% |
| NL | 4.1% | 1.2% |
| JP | 3.5% | 2.4% |
| FR | 0.6% | 3.2% |
| BM | 2.4% | — |
| DK | — | 2.4% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do GDOC and PHSYX overlap?
What stocks do GDOC and PHSYX have in common?
Should I own both GDOC and PHSYX?
Which holds more stocks, GDOC or PHSYX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.